Therefore, further studies of these DEP and DEPP would have profound significances for studying Elovl6 as a potential therapeutic target for many metabolic diseases such as type 2 diabetes, insulin resistance and fatty liver. The gene discussed is ELOVL6; the disease is type 2 diabetes mellitus.